379 related articles for article (PubMed ID: 1755460)
1. Use of the Home Ovarian Monitor in pregnancy avoidance.
Brown JB; Holmes J; Barker G
Am J Obstet Gynecol; 1991 Dec; 165(6 Pt 2):2008-11. PubMed ID: 1755460
[TBL] [Abstract][Full Text] [Related]
2. Monitoring of ovarian activity by measurement of urinary excretion rates using the Ovarian Monitor, Part IV: the relationship of the pregnanediol glucuronide threshold to basal body temperature and cervical mucus as markers for the beginning of the post-ovulatory infertile period.
Blackwell LF; Vigil P; Alliende ME; Brown S; Festin M; Cooke DG
Hum Reprod; 2016 Feb; 31(2):445-53. PubMed ID: 26677961
[TBL] [Abstract][Full Text] [Related]
3. The validation of the Billings ovulation method by laboratory research and field trials.
Billings JJ
Acta Eur Fertil; 1991; 22(1):9-15. PubMed ID: 1746210
[TBL] [Abstract][Full Text] [Related]
4. Using an ovarian monitor as an adjunct to natural family planning.
Cavero C
J Nurse Midwifery; 1995; 40(3):269-76. PubMed ID: 7798132
[TBL] [Abstract][Full Text] [Related]
5. Natural regulation of fertility.
Howie PW
Br Med Bull; 1993 Jan; 49(1):182-99. PubMed ID: 8324608
[TBL] [Abstract][Full Text] [Related]
6. A prototype for ovulation detection: pros and cons.
Lasley BL; Shideler SE; Munro CJ
Am J Obstet Gynecol; 1991 Dec; 165(6 Pt 2):2003-7. PubMed ID: 1755459
[TBL] [Abstract][Full Text] [Related]
7. Monitoring of ovarian activity by daily measurement of urinary excretion rates of oestrone glucuronide and pregnanediol glucuronide using the Ovarian Monitor, Part III: variability of normal menstrual cycle profiles.
Blackwell LF; Vigil P; Cooke DG; d'Arcangues C; Brown JB
Hum Reprod; 2013 Dec; 28(12):3306-15. PubMed ID: 24170744
[TBL] [Abstract][Full Text] [Related]
8. Personal hormone monitoring for contraception.
Bonnar J; Flynn A; Freundl G; Kirkman R; Royston R; Snowden R
Br J Fam Plann; 1999 Jan; 24(4):128-34. PubMed ID: 10023097
[TBL] [Abstract][Full Text] [Related]
9. Monitoring of ovarian activity by measurement of urinary excretion rates of estrone glucuronide and pregnanediol glucuronide using the Ovarian Monitor, Part II: reliability of home testing.
Blackwell LF; Vigil P; Gross B; d'Arcangues C; Cooke DG; Brown JB
Hum Reprod; 2012 Feb; 27(2):550-7. PubMed ID: 22131389
[TBL] [Abstract][Full Text] [Related]
10. More about natural family planning.
Gallagher J
Aust Fam Physician; 1983 Nov; 12(11):786-92. PubMed ID: 6667188
[TBL] [Abstract][Full Text] [Related]
11. A prospective multicentre trial of the ovulation method of natural family planning. II. The effectiveness phase.
Fertil Steril; 1981 Nov; 36(5):591-8. PubMed ID: 7308503
[TBL] [Abstract][Full Text] [Related]
12. Hormonal monitoring of ovarian activity using the Ovarian Monitor, part I. Validation of home and laboratory results obtained during ovulatory cycles by comparison with radioimmunoassay.
Blackwell LF; Brown JB; Vigil P; Gross B; Sufi S; d'Arcangues C
Steroids; 2003 May; 68(5):465-76. PubMed ID: 12798498
[TBL] [Abstract][Full Text] [Related]
13. The prediction and/or detection of ovulation by means of urinary steroid assays.
Cekan SZ; Beksac MS; Wang E; Shi S; Masironi B; Landgren BM; Diczfalusy E
Contraception; 1986 Apr; 33(4):327-45. PubMed ID: 3731775
[TBL] [Abstract][Full Text] [Related]
14. A prospective multicentre trial of the ovulation method of natural family planning. I. The teaching phase.
Fertil Steril; 1981 Aug; 36(2):152-8. PubMed ID: 7021189
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of ovulation by low-dose mifepristone (RU 486).
Ledger WL; Sweeting VM; Hillier H; Baird DT
Hum Reprod; 1992 Aug; 7(7):945-50. PubMed ID: 1331167
[TBL] [Abstract][Full Text] [Related]
16. Ovarian function after the menarche and hormonal contraception.
Borsos A; Lampé L; Balogh A; Csoknyay J; Ditròi F; Székely P
Int J Gynaecol Obstet; 1988 Oct; 27(2):249-53. PubMed ID: 2903093
[TBL] [Abstract][Full Text] [Related]
17. An evaluation of the Bioself 110 electronic fertility indicator as a contraceptive aid.
Flynn A; Pulcrano J; Royston P; Spieler J
Contraception; 1991 Aug; 44(2):125-39. PubMed ID: 1893707
[TBL] [Abstract][Full Text] [Related]
18. Further analysis of contraceptive failure of the ovulation method.
Trussell J; Grummer-Strawn L
Am J Obstet Gynecol; 1991 Dec; 165(6 Pt 2):2054-9. PubMed ID: 1755470
[TBL] [Abstract][Full Text] [Related]
19. Symptothermal and hormonal markers of potential fertility in climacteric women.
Flynn AM; James P; Collins WP; Royston P
Am J Obstet Gynecol; 1991 Dec; 165(6 Pt 2):1987-9. PubMed ID: 1755454
[TBL] [Abstract][Full Text] [Related]
20. An evaluation of teaching cervical mucus symptoms to ovulating infertile women.
Graham FM; Gosling L; France JT
Aust N Z J Obstet Gynaecol; 1983 Nov; 23(4):226-30. PubMed ID: 6585197
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
